Cost-effectiveness for metastatic colorectal cancer.

被引：1
|
作者：
Yao, Linli
Han, Jiaqi
She, Longjiang
Ding, Dong
Liao, Mengting
Hu, Huabin
Zeng, Shan
Shen, Liangfang
Huang, Jin
机构：
[1] Cent S Univ, Xiangya Hosp, Dept Oncol, Changsha, Hunan, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e15003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15003
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness of colorectal Cancer Screening
    Sailer, M.
    COLOPROCTOLOGY, 2012, 34 (06) : 441 - 442
  • [22] Cost-effectiveness of cetuximab for colorectal cancer
    Park, Taehwan
    Choi, Chang-ju
    Choi, Yeera
    Suh, Dong-Churl
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (06) : 667 - 677
  • [23] Cost-effectiveness of colorectal cancer screening
    Glick, SN
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (04): : 407 - 408
  • [24] The cost-effectiveness of screening for colorectal cancer
    Telford, Jennifer J.
    Levy, Adrian R.
    Sambrook, Jennifer C.
    Zou, Denise
    Enns, Robert A.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (12) : 1307 - 1313
  • [25] Cost-effectiveness of colorectal cancer screening
    McMahon, PM
    Bosch, JL
    Gleason, S
    Halpern, EF
    Lester, JS
    Gazelle, GS
    RADIOLOGY, 2001, 219 (01) : 44 - 50
  • [26] Cost-effectiveness in the prevention of colorectal cancer
    Sonnenberg, A
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2002, 31 (04) : 1069 - +
  • [27] Cost-effectiveness of RAS testing in colorectal cancer. A systematic review of economic evaluations
    Unim, B.
    Pitini, E.
    D'Andrea, E.
    De Vito, C.
    Marzuillo, C.
    Villari, P.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2018, 28 : 93 - 93
  • [28] Adjuvant chemotherapy in Dukes' B and C colorectal cancer. A cost-effectiveness analysis
    Norum, J
    Olsen, JA
    Revhaug, A
    Vonen, B
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1103 - 1103
  • [29] Evaluation of the Cost-effectiveness of Doublet Therapy in Metastatic BRAF Variant Colorectal Cancer
    Patel, Kishan K.
    Stein, Stacey
    Lacy, Jill
    O'Hara, Mark
    Huntington, Scott F.
    JAMA NETWORK OPEN, 2021, 4 (01) : E2033441
  • [30] Cost-effectiveness analysis of fruquintinib in Chinese patients with refractory metastatic colorectal cancer
    Huang, Zijia
    Zhou, Lingyan
    Zheng, Hanrui
    Zhan, Mei
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024, 46 (04) : 872 - 880
12345